Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
INSM | INSMED Inc | Chief Financial Officer | $8.75M | -$29M | -76.8% | Jul 21, 2025 |
SCPH | scPharmaceuticals Inc. | Director | Oct 7, 2025 | |||
XLO | Xilio Therapeutics, Inc. | Director | Jun 11, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|